Iviomics, a global leader in genetic diagnostics and pioneer in the
field of reproductive genetics, has introduced a new technology in India
to determine the exact time of transfer of embryo into the uterus.The
new European technology- Endometrial Receptivity Array (ERA)- is aimed
at having accurate genetic screening of a healthy disease free embryo,
thus helping the couples improve their chances of having a healthy baby,
said a release here.These not only promise to increase their
chances of a successful parenthood, but also reduce the number of IVF
cycles that they might otherwise be needed to be subjected to. The first
of its kind, Iviomics lab offers international technology for a safer,
faster and more accurate method of identification and selection of
healthy, disease-free embryos.
Iviomics India Lab manger Dr Pere said in a release that in couples with recurrent miscarriages, 80% of the embryos are chromosomally abnormal and upto 15% patients have all the embryos which are chromosomally abnormal. These couples therefore would never have a chance of conceiving a healthy offspring. “Previously, the IVF clinics had no choice but to repeat the IVF cycles till there was a success or otherwise. Now, after Array CGH analysis only those embryos which are chromosomally normal are transferred to the uterus which increases the success rate of pregnancy and implantation. This simultaneously reduces the risk of miscarriages or having a live born child with chromosomal abnormality like Down’s syndrome,” he claimed.The lab also provides PGD services (Preimplantational Genetic Diagnosis) which can help couples with a personal or family history of genetically inherited disorders to have healthy babies. Iviomics has a developed a PGD protocol for more than 150 single gene disorders, he added.Iviomics, which claims to be performing the highest number of PGD procedures in Europe, has branches in New Delhi (India), Los Angeles and Miami (USA), Valencia (Spain) and Milan (Italy).
Source:Pharmabiz
Iviomics India Lab manger Dr Pere said in a release that in couples with recurrent miscarriages, 80% of the embryos are chromosomally abnormal and upto 15% patients have all the embryos which are chromosomally abnormal. These couples therefore would never have a chance of conceiving a healthy offspring. “Previously, the IVF clinics had no choice but to repeat the IVF cycles till there was a success or otherwise. Now, after Array CGH analysis only those embryos which are chromosomally normal are transferred to the uterus which increases the success rate of pregnancy and implantation. This simultaneously reduces the risk of miscarriages or having a live born child with chromosomal abnormality like Down’s syndrome,” he claimed.The lab also provides PGD services (Preimplantational Genetic Diagnosis) which can help couples with a personal or family history of genetically inherited disorders to have healthy babies. Iviomics has a developed a PGD protocol for more than 150 single gene disorders, he added.Iviomics, which claims to be performing the highest number of PGD procedures in Europe, has branches in New Delhi (India), Los Angeles and Miami (USA), Valencia (Spain) and Milan (Italy).
Source:Pharmabiz
No comments:
Post a Comment